Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Biofilm Formation Drives Transfer of the Conjugative Element ICEBs1 in Bacillus subtilis.

Lécuyer F, Bourassa JS, Gélinas M, Charron-Lamoureux V, Burrus V, Beauregard PB.

mSphere. 2018 Sep 26;3(5). pii: e00473-18. doi: 10.1128/mSphere.00473-18.

2.

High-efficiency second generation ethanol from the hemicellulosic fraction of softwood chips mixed with construction and demolition residues.

Boboescu IZ, Gélinas M, Beigbeder JB, Lavoie JM.

Bioresour Technol. 2018 Oct;266:421-430. doi: 10.1016/j.biortech.2018.06.056. Epub 2018 Jun 20.

PMID:
29990759
3.

A two-step optimization strategy for 2nd generation ethanol production using softwood hemicellulosic hydrolysate as fermentation substrate.

Boboescu IZ, Gélinas M, Beigbeder JB, Lavoie JM.

Bioresour Technol. 2017 Nov;244(Pt 1):708-716. doi: 10.1016/j.biortech.2017.07.107. Epub 2017 Jul 29.

PMID:
28822282
4.

Variation in Parasite Communities in Spottail Shiners (Notropis hudsonius) Linked with Precipitation.

Marcogliese DJ, Locke SA, Gélinas M, Gendron AD.

J Parasitol. 2016 Feb;102(1):27-36. doi: 10.1645/12-31. Epub 2015 Oct 14.

PMID:
26465386
5.

Responses of freshwater mussel (Elliptio complanata) hemocytes exposed in vitro to crude extracts of Microcystis aeruginosa and Lyngbya wollei.

Gélinas M, Fortier M, Lajeunesse A, Fournier M, Gagnon C, Barnabé S, Gagné F.

Ecotoxicology. 2014 Mar;23(2):260-6. doi: 10.1007/s10646-013-1169-3. Epub 2014 Jan 7.

PMID:
24395509
6.

Temporal and seasonal variation in acetylcholinesterase activity and glutathione-S-transferase in amphipods collected in mats of Lyngbya wollei in the St-Lawrence River (Canada).

Gélinas M, Lajeunesse A, Gagnon C, Gagné F.

Ecotoxicol Environ Saf. 2013 Aug;94:54-9. doi: 10.1016/j.ecoenv.2013.04.017. Epub 2013 May 20.

PMID:
23702304
7.

Energy status and immune system alterations in Elliptio complanata after ingestion of cyanobacteria Anabaena flos-aquae.

Gélinas M, Fortier M, Lajeunesse A, Fournier M, Gagnon C, Gagné F.

Ecotoxicology. 2013 Apr;22(3):457-68. doi: 10.1007/s10646-012-1039-4. Epub 2013 Jan 26.

PMID:
23354932
8.

Stress-related gene expression changes in rainbow trout hepatocytes exposed to various municipal wastewater treatment influents and effluents.

Gagné F, Smyth SA, André C, Douville M, Gélinas M, Barclay K.

Environ Sci Pollut Res Int. 2013 Mar;20(3):1706-18. doi: 10.1007/s11356-012-1174-8. Epub 2012 Sep 21.

PMID:
23010963
9.

Toxicity of silver nanoparticles to rainbow trout: a toxicogenomic approach.

Gagné F, André C, Skirrow R, Gélinas M, Auclair J, van Aggelen G, Turcotte P, Gagnon C.

Chemosphere. 2012 Oct;89(5):615-22. doi: 10.1016/j.chemosphere.2012.05.063. Epub 2012 Jun 23.

PMID:
22727896
10.

In vitro immunotoxicity of environmentally representative antibiotics to the freshwater mussel Elliptio complanata.

Gust M, Gélinas M, Fortier M, Fournier M, Gagné F.

Environ Pollut. 2012 Oct;169:50-8. doi: 10.1016/j.envpol.2012.05.020. Epub 2012 Jun 7.

PMID:
22683480
11.

Early biochemical effects of Microcystis aeruginosa extracts on juvenile rainbow trout (Oncorhynchus mykiss).

Gélinas M, Juneau P, Gagné F.

Comp Biochem Physiol B Biochem Mol Biol. 2012 Mar;161(3):261-7. doi: 10.1016/j.cbpb.2011.12.002. Epub 2011 Dec 10.

PMID:
22178707
12.

Detection and confirmation of saxitoxin analogues in freshwater benthic Lyngbya wollei algae collected in the St. Lawrence River (Canada) by liquid chromatography-tandem mass spectrometry.

Lajeunesse A, Segura PA, Gélinas M, Hudon C, Thomas K, Quilliam MA, Gagnon C.

J Chromatogr A. 2012 Jan 6;1219:93-103. doi: 10.1016/j.chroma.2011.10.092. Epub 2011 Nov 7.

PMID:
22169195
13.

Factors associated with weight loss during radiotherapy in patients with stage I or II head and neck cancer.

Nourissat A, Bairati I, Fortin A, Gélinas M, Nabid A, Brochet F, Têtu B, Meyer F.

Support Care Cancer. 2012 Mar;20(3):591-9. doi: 10.1007/s00520-011-1132-x. Epub 2011 Mar 20.

PMID:
21424341
14.

Neurochemical effects of benzodiazepine and morphine on freshwater mussels.

Gagné F, André C, Gélinas M.

Comp Biochem Physiol C Toxicol Pharmacol. 2010 Aug;152(2):207-14. doi: 10.1016/j.cbpc.2010.04.007. Epub 2010 Apr 14.

PMID:
20398796
15.

Predictors of weight loss during radiotherapy in patients with stage I or II head and neck cancer.

Nourissat A, Bairati I, Samson E, Fortin A, Gélinas M, Nabid A, Brochet F, Têtu B, Meyer F.

Cancer. 2010 May 1;116(9):2275-83. doi: 10.1002/cncr.25041.

16.

Health-related quality of life as a survival predictor for patients with localized head and neck cancer treated with radiation therapy.

Meyer F, Fortin A, Gélinas M, Nabid A, Brochet F, Têtu B, Bairati I.

J Clin Oncol. 2009 Jun 20;27(18):2970-6. doi: 10.1200/JCO.2008.20.0295. Epub 2009 May 18.

PMID:
19451440
17.

Treatment results of carcinoma in situ of the glottic larynx: 61 patients treated with radiotherapy.

Charbonneau N, Gélinas M, del Vecchio P, Guertin L, Larochelle D, Tabet JC, Souliàres D, Charpentier D, Félix Nguyen-Tân P.

J Otolaryngol Head Neck Surg. 2008 Aug;37(4):572-6.

PMID:
19128595
18.

Phase 2 study of silver leaf dressing for treatment of radiation-induced dermatitis in patients receiving radiotherapy to the head and neck.

Vavassis P, Gelinas M, Chabot Tr J, Nguyen-Tân PF.

J Otolaryngol Head Neck Surg. 2008 Feb;37(1):124-9.

PMID:
18479639
19.

Prognostic significance of cyclooxygenase-2 overexpression in glottic cancer.

Sackett MK, Bairati I, Meyer F, Jobin E, Lussier S, Fortin A, Gélinas M, Nabid A, Brochet F, Têtu B.

Clin Cancer Res. 2008 Jan 1;14(1):67-73. doi: 10.1158/1078-0432.CCR-07-2028.

21.
22.

Primary radiotherapy for tonsillar carcinoma: a good alternative to a surgical approach.

Charbonneau N, Gélinas M, del Vecchio P, Guertin L, Larochelle D, Tabet JC, Soulières D, Charpentier D, Nguyen-Tân PF.

J Otolaryngol. 2006 Aug;35(4):227-34.

PMID:
17176797
23.

Role of neck dissection following concurrent chemoradiation for advanced head and neck carcinoma.

Forest VI, Nguyen-Tan PF, Tabet JC, Olivier MJ, Larochelle D, Fortin B, Gélinas M, Soulières D, Charpentier D, Guertin L.

Head Neck. 2006 Dec;28(12):1099-105.

PMID:
16933313
24.

Antioxidant vitamins supplementation and mortality: a randomized trial in head and neck cancer patients.

Bairati I, Meyer F, Jobin E, Gélinas M, Fortin A, Nabid A, Brochet F, Têtu B.

Int J Cancer. 2006 Nov 1;119(9):2221-4.

25.

Randomized trial of antioxidant vitamins to prevent acute adverse effects of radiation therapy in head and neck cancer patients.

Bairati I, Meyer F, Gélinas M, Fortin A, Nabid A, Brochet F, Mercier JP, Têtu B, Harel F, Abdous B, Vigneault E, Vass S, Del Vecchio P, Roy J.

J Clin Oncol. 2005 Aug 20;23(24):5805-13. Epub 2005 Jul 18.

PMID:
16027437
26.

Retromolar trigone carcinoma treated by primary radiation therapy: an alternative to the primary surgical approach.

Ayad T, Gélinas M, Guertin L, Larochelle D, Del Vecchio P, Tabet JC, Olivier MJ, Soulières D, Charpentier D, Nguyen-Tân PF.

Arch Otolaryngol Head Neck Surg. 2005 Jul;131(7):576-82.

PMID:
16027279
27.

A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients.

Bairati I, Meyer F, Gélinas M, Fortin A, Nabid A, Brochet F, Mercier JP, Têtu B, Harel F, Mâsse B, Vigneault E, Vass S, del Vecchio P, Roy J.

J Natl Cancer Inst. 2005 Apr 6;97(7):481-8.

PMID:
15812073
28.

Strategic planning: five common problems with the implementation phase.

Gelinas MA.

J Oncol Manag. 2004 May-Jun;13(3):14-9.

PMID:
15290907
30.

Strategic planning: the first step in the planning process.

Gelinas MA.

J Oncol Manag. 2003 May-Jun;12(3):11-4.

PMID:
12803445
31.

Prophylaxis of radiation-associated mucositis in conventionally treated patients with head and neck cancer: a double-blind, phase III, randomized, controlled trial evaluating the clinical efficacy of an antimicrobial lozenge using a validated mucositis scoring system.

El-Sayed S, Nabid A, Shelley W, Hay J, Balogh J, Gelinas M, MacKenzie R, Read N, Berthelet E, Lau H, Epstein J, Delvecchio P, Ganguly PK, Wong F, Burns P, Tu D, Pater J.

J Clin Oncol. 2002 Oct 1;20(19):3956-63.

PMID:
12351592
32.

Coaching the leader: first step in successful change.

Gelinas MV, James RG.

Healthc Benchmarks. 1999 Oct;6(10):117-8. No abstract available.

PMID:
10621089
33.

Foundation for change built on four cornerstones.

Gelinas MV, James RG.

Healthc Benchmarks. 1999 Aug;6(8):92-4.

PMID:
10557761
34.

Learn how to aid organizational change.

Gelinas MV, James RG.

Healthc Benchmarks. 1999 Sep;6(9):105-6.

PMID:
10557414
35.

Mission creates winning approach to care.

Gelinas MV, James RG.

Provider. 1999 Jul;25(7):suppl 15-6. No abstract available.

PMID:
10539078
36.

Is your benchmarking missing the mark?

Gelinas MV, James RG.

Healthc Benchmarks. 1999 Jun;6(6):68-70. No abstract available.

PMID:
10538097
37.

Delivery of trifluridine to human cornea and aqueous using collagen shields.

Kuster P, Taravella M, Gelinas M, Stepp P.

CLAO J. 1998 Apr;24(2):122-4.

PMID:
9571274
38.

Association between dietary adherence measures and glycemic control in outpatients with type 1 diabetes mellitus and normal serum lipid levels.

Strychar IM, Blain E, Rivard M, Gélinas MD, Radwan F, Crawhall JC.

J Am Diet Assoc. 1998 Jan;98(1):76-9. No abstract available.

PMID:
9434655
39.

Immunization survey of non-institutionalized adults--Quebec (as of May 30, 1996).

Duclos P, Arruda H, Dessau JC, Dion R, Dupont M, Gaulin C, Grenier JL, Savard M, Trudeau G, Douville-Fradet M, Beauséjour D, Bergeron A, Bergeron JP, Castonguay M, Clermont P, Cloutier J, Côté L, Czyziw E, Dubuc M, D'Halewyn MA, Fortin A, Frigon M, Gélinas M, Kirouac I, Venne S, et al.

Can Commun Dis Rep. 1996 Nov 1;22(21):177-81. English, French. No abstract available.

40.

[Incidence and risk factors of second primary cancers in patients treated for primary pharyngeal cancer].

Brochet F, Bairati I, Roy J, Gélinas M, Nabid A, Têtu B, Mâsse B, Meyer F.

Bull Cancer Radiother. 1996;83(1):8-11. Review. French.

PMID:
8679284
41.

[Prevention of second primary cancer with vitamin supplementation in patients treated for head and neck cancers].

Bairati I, Brochet F, Roy J, Gélinas M, Nabid A, Têtu B, Mâsse B, Meyer F.

Bull Cancer Radiother. 1996;83(1):12-6. Review. French.

PMID:
8679274
42.

Impact of magnetic resonance imaging and computed tomography on the staging of laryngeal cancer.

Katsounakis J, Remy H, Vuong T, Gélinas M, Tabah R.

Eur Arch Otorhinolaryngol. 1995;252(4):206-8.

PMID:
7546674
43.

Comparison of anthropometric measures of men with HIV: asymptomatic, symptomatic, and AIDS.

Parisien C, Gélinas MD, Cossette M.

J Am Diet Assoc. 1993 Dec;93(12):1404-8.

PMID:
8245374
44.

Rapid improvement of hyperlipidemia in kidney transplant patients with a multifactorial hypolipidemic diet.

Nelson J, Beauregard H, Gélinas M, St-Louis G, Daloze P, Smeesters C, Corman J.

Transplant Proc. 1988 Dec;20(6):1264-70. No abstract available.

PMID:
3059616
45.

Phase I study of 13-cis-retinoic acid toxicity.

Band PR, Besner JG, Leclaire R, Girard C, Diorio G, Deschamps M, Gélinas M, Larochelle D.

Cancer Treat Rep. 1982 Sep;66(9):1759-61.

PMID:
7116351
46.

Exocrine pancreatic function following proximal small bowel resection in rats.

Gelinas MD, Morin CL, Morisset J.

J Physiol. 1982 Jan;322:71-82.

47.

Therapeutic results in 265 cases of laryngeal cancer.

Gelinas M, Methot F, Gagnon NB.

J Otolaryngol. 1981 Apr;10(2):137-48.

PMID:
7241629
48.

Cancer of the oral cavity.

Gelinas M, Blondeau F.

J Otolaryngol. 1981 Feb;10(1):17-22.

PMID:
7206023
49.

[Cancer of the hypopharynx, results in patients treated at Notre Dame Hospital from 1970 to 1977].

Méthot F, Gélinas M.

Union Med Can. 1981 Jan;110(1):55-60. French. No abstract available.

PMID:
7210336
50.

Effects of bile and pancreatic secretions on intestinal mucosa after proximal small bowel resection in rats.

Gélinas MD, Morin CL.

Can J Physiol Pharmacol. 1980 Sep;58(9):1117-23.

PMID:
7459702

Supplemental Content

Loading ...
Support Center